Genetesis adds 3 to executive team as FDA 'de novo' approval looms By: Cincinnati Business Courier via Business Journals January 23, 2023 at 14:47 PM EST Genetesis has added three new executives to its team as it nears a key FDA approval. Read More >> Related Stocks: Harbor Disruptive Innovation ETF
